Blossom Health Raises $20M to Scale AI-Powered Psychiatry Platform…

Team S · 2026-04-01T14:32:12.000Z

New York-based healthtech startup Blossom Health has raised $20 million across Seed and Series A funding rounds, as it looks to expand its AI-powered psychiatry platform and improve access to mental healthcare. The round was led by Headline, with participation from Village Global, TA Ventures, Operator Partners, and Correlation Ventures, along with a group of angel investors from leading tech and healthcare companies. Founded in 2024 by John Zhao, Blossom Health is building an AI-native operating system for psychiatry that combines clinical decision support with automated administrative workflows. The platform uses AI “copilots” to assist psychiatrists with diagnosis, treatment planning, and patient monitoring, while also handling time-consuming tasks such as documentation, billing, and scheduling. The company is addressing a major bottleneck in mental healthcare, where clinicians often spend nearly half their time on non-clinical work, limiting patient access and increasing wait times. Blossom’s solution aims to increase provider capacity and deliver faster, more continuous care, with patients often able to access treatment within days. Blossom Health has already gained early traction, with its platform used by hundreds of clinicians treating over 10,000 patients across multiple US states. The newly raised capital will be used to expand into additional states, deepen partnerships with insurers, onboard more clinicians, and further develop its AI capabilities. The funding reflects a growing trend of investment in AI-driven healthcare infrastructure, particularly solutions that augment clinicians rather than replace them, enabling scalable and high-quality care delivery in underserved sectors like mental health.

Member Login Get Access

Blossom Health Raises $20M to Scale AI-Powered Psychiatry Platform… | Newnex